SYRS Financial Facts

See Full Income Statement

See Full Balance Sheet

Syros Pharmaceuticals (SYRS) Earnings

  |   Expand Research on SYRS
Next EPS Date 8/6/21 *Est. EPS Growth Rate +41.0% *Last Qtr.
Average EPS % Beat Rate +10.1% Revenue Growth Rate +102.9% *Last Qtr.
Average % Move 1-Wk after EPS +0.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/6/21 Q121 -$0.23-$0.46 +$0.23$4.83M$2.67M N/A Details
3/4/21 Q420 -$0.62-$0.50 -$0.12$5.7M$2.7M N/A Details
11/5/20 Q320 N/A-$0.38 N/A N/A$2.54M N/A N/A N/A
8/6/20 Q220 -$0.38-$0.40 +$0.02$3.19M$1.9M N/A Details
5/7/20 Q120 -$0.39-$0.43 +$0.04$2.38M$1.62M N/A Details
3/5/20 Q419 -$0.46-$0.47 +$0.01N/A$690K N/A Details
11/12/19 Q319 -$0.47-$0.48 +$0.01$558K$440K N/A Details
8/1/19 Q219 -$0.47-$0.42 -$0.05$462K$430K N/A Details